
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL | 5,297 | 98.2% | 0.03 | 5,402 | 99.3% |
| CentralBrain-unspecified | 82 | 1.5% | -1.04 | 40 | 0.7% |
| LAL | 13 | 0.2% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns ORN_DL3 | % In | CV |
|---|---|---|---|---|---|
| ORN_DL3 | 103 | ACh | 19.2 | 56.0% | 0.5 |
| lLN2T_b | 3 | ACh | 3.7 | 10.8% | 0.0 |
| lLN2F_a | 3 | unc | 2.2 | 6.5% | 0.1 |
| ALIN5 | 2 | GABA | 2.1 | 6.3% | 0.0 |
| lLN2T_e | 4 | ACh | 1.9 | 5.5% | 0.5 |
| lLN2P_b | 6 | GABA | 1.5 | 4.4% | 0.7 |
| v2LN36 | 2 | Glu | 0.7 | 2.0% | 0.0 |
| ORN_DL4 | 27 | ACh | 0.7 | 1.9% | 0.9 |
| DL3_lPN | 8 | ACh | 0.5 | 1.5% | 0.6 |
| lLN2F_b | 4 | GABA | 0.5 | 1.5% | 0.9 |
| ORN_DA1 | 22 | ACh | 0.3 | 0.7% | 0.4 |
| lLN2P_a | 1 | GABA | 0.2 | 0.6% | 0.0 |
| lLN1_bc | 10 | ACh | 0.2 | 0.6% | 0.6 |
| il3LN6 | 1 | GABA | 0.1 | 0.4% | 0.0 |
| lLN2T_c | 3 | ACh | 0.1 | 0.4% | 0.0 |
| lLN2X04 | 3 | ACh | 0.1 | 0.3% | 0.4 |
| v2LN30 | 2 | unc | 0.0 | 0.1% | 0.0 |
| lLN2X12 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| lLN2T_a | 2 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DM3 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DA2 | 1 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DA3 | 2 | ACh | 0.0 | 0.1% | 0.0 |
| ORN_DL1 | 2 | ACh | 0.0 | 0.1% | 0.0 |
| DA1_lPN | 2 | ACh | 0.0 | 0.1% | 0.0 |
| CSD | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| ORN_DA4l | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_ilPNm90 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| CB3679 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| AL-MBDL1 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_D | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DL5 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ORN_DL3 | % Out | CV |
|---|---|---|---|---|---|
| DL3_lPN | 11 | ACh | 71.2 | 46.8% | 0.3 |
| ORN_DL3 | 103 | ACh | 19.2 | 12.6% | 0.6 |
| lLN2T_b | 3 | ACh | 10.2 | 6.7% | 0.1 |
| lLN2P_b | 8 | GABA | 9.3 | 6.1% | 1.0 |
| v2LN36 | 2 | Glu | 8.3 | 5.5% | 0.0 |
| lLN2P_a | 3 | GABA | 6.6 | 4.4% | 0.5 |
| lLN2F_a | 4 | unc | 6.3 | 4.2% | 0.5 |
| v2LN30 | 2 | unc | 4.6 | 3.0% | 0.0 |
| lLN2T_c | 3 | ACh | 3.3 | 2.2% | 0.4 |
| lLN2T_e | 4 | ACh | 2.1 | 1.4% | 0.5 |
| lLN2F_b | 4 | GABA | 2.0 | 1.3% | 1.0 |
| il3LN6 | 1 | GABA | 1.8 | 1.2% | 0.0 |
| ALIN7 | 2 | GABA | 1.2 | 0.8% | 0.0 |
| lLN2T_a | 4 | ACh | 1.1 | 0.7% | 0.8 |
| lLN2X04 | 3 | ACh | 0.9 | 0.6% | 0.5 |
| ORN_DL4 | 34 | ACh | 0.7 | 0.4% | 0.6 |
| ORN_DA1 | 43 | ACh | 0.7 | 0.4% | 0.7 |
| lLN2P_c | 3 | GABA | 0.6 | 0.4% | 0.6 |
| ALIN5 | 2 | GABA | 0.4 | 0.2% | 0.0 |
| DL4_adPN | 1 | ACh | 0.3 | 0.2% | 0.0 |
| lLN2X12 | 1 | ACh | 0.3 | 0.2% | 0.0 |
| CB3679 | 1 | ACh | 0.2 | 0.1% | 0.0 |
| lLN1_bc | 7 | ACh | 0.1 | 0.1% | 0.7 |
| v2LN3A | 2 | unc | 0.1 | 0.1% | 0.0 |
| ALIN4 | 1 | GABA | 0.1 | 0.1% | 0.0 |
| M_lvPNm24 | 3 | ACh | 0.1 | 0.1% | 0.5 |
| CB2845 | 3 | unc | 0.1 | 0.1% | 0.5 |
| M_ilPNm90 | 1 | ACh | 0.1 | 0.0% | 0.0 |
| M_l2PNm16 | 2 | ACh | 0.1 | 0.0% | 0.0 |
| ORN_DA3 | 2 | ACh | 0.0 | 0.0% | 0.3 |
| AL-MBDL1 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| DC1_adPN | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DL1 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DC4 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| M_vPNml50 | 1 | GABA | 0.0 | 0.0% | 0.0 |
| CSD | 1 | 5-HT | 0.0 | 0.0% | 0.0 |
| M_lvPNm35 | 1 | ACh | 0.0 | 0.0% | 0.0 |
| DNc01 | 1 | unc | 0.0 | 0.0% | 0.0 |
| v2LN3A1_b | 1 | ACh | 0.0 | 0.0% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 0.0 | 0.0% | 0.0 |
| DA1_lPN | 1 | ACh | 0.0 | 0.0% | 0.0 |
| ORN_DA4m | 1 | ACh | 0.0 | 0.0% | 0.0 |
| AL-AST1 | 1 | ACh | 0.0 | 0.0% | 0.0 |